Djuna Competitors

HealthEdge® guarantees payers an enduring financial edge in an increasingly competitive environment. We combine an AI-powered technology platform with proven, end-to-end operational solutions across the payer enterprise. This delivers measurable financial outcomes and absorbs the risk that has historically come with transformation. By unifying data and locking in performance improvements that compound over time, HealthEdge enables payers to operate more efficiently, strengthen margins, and respond faster to members and the market. With HealthEdge, transformation is an enduring competitive advantage. Learn more at HealthEdge.com

Since 1999, Biovita Group is committed to helping people taking care of their well-being and pursuing a healthy lifestyle. Biovita Group is the exclusive distributor in Italy of the renowned brands Jamieson Laboratories Ltd and PowerBar®, covering a wide range of the food and nutrition supplements, vitamins and minerals market. Thanks to its long-time experience and knowhow in this industry, in 2011 Biovita launched WHYsport brand in the market, a line of food supplements for sports people and athletes who want to optimize physical efforts and improve their performance. Willing to meet everyone’s need, in 2017 Biovita launched a second brand, WHYnature, the line of food supplements dedicated to those athletes who follow a vegetarian/vegan diet or have specific allergies/intolerances. To guarantee the highest quality standards, WHYsport and WHYnature products undergo strict quality controls during the research & development phase, in the ingredients selection, during the production and storage phases. The main features that make the company and brands stand out are: • top quality ingredients used in production • brands ownership • production high standards and procedures (with reference to owned brands WHYsport and WHYnature) • highest level of research & development • multi-year experience and knowhow in the market and this industry

Breathe Life Sciences (BXN:ASX) is an Australian multi-national life sciences company focused on research, development, manufacture, and wholesale of novel pharmaceuticals, medicinal cannabis, psilocybin, consumer health and lifestyle products. In 2023 BLS was acquired by Bioxyne (BXN:ASX). The merged group has head offices in Sydney, London, Prague, and Nagoya. The Company operates in Australia, the United Kingdom, Germany, France, Czechia, Japan, and the United States. https://bioxyne.com/